Showing results (1-10 of 814) with videos related to
Sort By:
Pageof 82
Journal of the American College of Cardiology|December 13, 2006
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in womenBrendan M Everett, Tobias Kurth, Julie E Buring, et al.Clinical Therapeutics|May 24, 2008
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trialBrendan M Everett, Robert J Glynn, Eleanor Danielson, et al.The American Journal of Cardiology|June 18, 2015
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study)Brendan M Everett, Paul M Ridker, Nancy R Cook, et al.Circulation|December 23, 2009
Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)Brendan M Everett, Robert J Glynn, Jean G MacFadyen, et al.Atherosclerosis|June 3, 2008
Interleukin-18 and the risk of future cardiovascular disease among initially healthy womenBrendan M Everett, Sandeep Bansal, Nader Rifai, et al.Circulation|April 1, 2015
High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapyBrendan M Everett, Tanja Zeller, Robert J Glynn, et al.The American Journal of Cardiology|December 3, 2014
Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER)Brendan M Everett, Samia Mora, Robert J Glynn, et al.JAMA|September 17, 2009
Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trialAruna D Pradhan, Brendan M Everett, Nancy R Cook, et al.The American Journal of Cardiology|January 8, 2016
Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T ConcentrationsPratyaksh K Srivastava, Aruna D Pradhan, Nancy R Cook, et al.Journal of the American College of Cardiology|December 3, 2014
B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of womenBrendan M Everett, Jeffrey S Berger, JoAnn E Manson, et al.Pageof 82